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ABSTRACT 
NANOSECOND PULSED ELECTRIC FIELDS INDUCE A 
MITOCHONDRIA-INDEPENDENT APOPTOSIS IN B16F10 
MELANOMA CELLS IN VITRO 
Wentia Elissa Ford 
Old Dominion University, 2008 
Director: Dr. Stephen Beebe 
Nanosecond pulsed electric fields (nsPEFs) are ultra-short pulses that induce 
direct electric field and biological effects that initiate apoptosis. Here the application of 
ten 300ns pulses ranging in electric fields from 12kV/cm-60kV/cm was administered to 
determine the effects on B16F10 melanoma cells evaluated by in vitro studies. Initial 
application of nsPEFs demonstrated apoptosis induction in an electric field- and pulse 
number-dependent manner measured by caspase activation that correlated with decrease 
in cell viability 24hr post pulse. In addition caspase activity was shown to be 
independent of calcium mobilization though ions may play a part in other aspects of 
apoptosis. The use of additional apoptotic markers Annexin V and propidium iodide 
revealed no phosphatidylserine externalization and no direct electric field effects on 
membrane permeability, respectively. However, characteristic apoptotic morphological 
features of plasma membrane blebbing and F-actin cytoskeleton disruption were 
observed. In order to define apoptotic pathway, evaluation of mitochondrial function 
illustrated no intracellular release of mitochondrial proteins, cytochrome c, second 
mitochondria-derived activator of caspase (Smac), direct IAP-binding protein (DIABLO) 
and apoptosis inducing factor (AIF). Further examination of caspases with isozymes 
specific initiators indicated electric field-dependent increases in caspases -8 and 
interestingly -9 as well as executioner caspases -3, -6 and -7. 
NsPEFs activate signal transduction mechanisms that induce apoptosis through a 
mitochondria independent pathway that mimics an apparent membrane-dependent 
extrinsic type I apoptotic mechanism(s). Uniquely, nsPEF activate caspase -9 either via 
direct cleavage or an unknown mechanism without apoptosome formation in the 
mitochondria-dependent apoptotic pathway. Therefore nsPEFs induce apoptosis rapidly 
by mechanisms that are distinct and independent from those that are commonly mutant in 
the mitochondria pathway in melanomas and those same mechanisms frequently used by 
chemotherapeutic agents that result in resistant tumors. The short nsPEF treatment time 
(3 milliseconds) and rapid apoptosis induction (tens of minutes) is less likely to result in 
cancers that are resistant to nsPEF treatment. The therapeutic application of nsPEFs can 
provide a new and novel method to the arsenal for cancer treatment strategies. 
This dissertation is dedicated to my mother, Evangeline Ford, for her unselfish sacrifice, 
dedication and support throughout the completion of this degree. 
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CHAPTER I 
BACKGROUND, SPECIFIC AIMS AND SIGNIFICANCE 
BACKGROUND 
The Skin 
The skin is known as the largest organ in the body that accounts for 
approximately sixteen percent of the total body weight in adults. The skin serves as a 
protective barrier against physical, chemical, and biological toxic substances as well as an 
immunological organ that is composed of three layers, the epidermis, dermis and 
subcutaneous adipose tissue (Mills, 2007). The epidermis, the outermost (external) layer 
of skin, consists primarily of a stratified squamous keratinized epithelium comprised of 
five layers of keratinocytes. From the outermost to innermost epidermal layer, they are 
the (i) stratum corneum, flattened non-nucleated keratinized cells that consist of fifteen to 
twenty layers; (ii) stratum lucidum, composed of three to five layers of translucent thin 
flattened eosinophillic epidermal cells with no organelles and nuclei and cytoplasm 
composed of keratin filaments; (iii) stratum granulosum, composed of three to five layers 
of flattened polygonal cells that contain coarse basophilic granules intracellularly and 
protects against invasion by foreign materials and essential in the sealing effect in the 
skin; (iv) stratum spinosum, contains two to three layers of cuboidal or slightly flattened 
cells with central nucleus and keratin filaments in cytoplasm that holds cells together and 
preventing the effects of abrasion; and (v) stratum basale (stratum germinativum), the 
lowermost epidermal layer adjacent to the dermis characterized by one to two layers of 
The journal model used for this dissertation was Biophysical Journal 
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basophilic columnar or cuboidal cells that contain stem cells distinguished by rapid 
mitotic division and replenishment of epidermal cells (Junqueira and Carneiro 2005). 
The multilayer dermis is the subsequent supportive connective tissue layer 
between the epidermis and subcutaneous adipose tissue layer. The layer is abundant in 
nerve supply contains cellular components, tiny blood and lymph vessels, macrophages, 
extravasated leukocytes, collagen fibrils, elastic fibers (responsible for skin elasticity) and 
epidermal derivatives that include hair follicles and sweat and sebaceous glands. Lastly, 
the subcutaneous adipose tissue layer, the deepest skin layer, has connective tissue that 
attaches the skin loosely to the underlying organs and adipose cells that differ in content 
depending on the location in the body and physical state of individual (Junqueira and 
Carneiro 2005). 
Melanoma 
Melanoma is a form of skin cancer that results from a disease in the pigment 
producing cell, melanocytes. These cells, responsible for skin color, are located in the 
lowermost part of the epidermis called the stratum basale (stratum germinativum). 
Though there are many factors that attribute to skin color, melanin and carotene content, 
blood vessels in the dermis and blood flow through these vessels are the main 
components. Melanocytes produce a dark brown pigment, eumelanin found beneath or 
between cells of the stratum basale and hair follicles. These cells have spherical cell 
bodies with long irregular projections that extend between the strata basale and spinosum. 
Cells are anchored to basal lamina by hemidesmosomes. The activity of tyrosinase plays 
an essential part in the synthesis of melanin by melanocytes. Tyrosinase activity is 
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initially involved in converting 3,4-dihydroxy-phenylalanine (dopa) to dopaquinone 
which after a series of transformations produces melanin (Junqueira and Carneiro 2005). 
The maturation of melanin granules are categorized into four stages. Initially 
tyrosinase activity and formation of fine granular material is initiated by membrane 
enclosing a vesicle. Tyrosinase molecules on the protein matrix become present on the 
periphery of electron dense strands. The vesicle (melanosome) then deposits melanin on 
the protein matrix. This results in the enhancement of melanin production. Finally the 
melanin granule matures completely filling the vesicle. After formation, the melanin 
granules move toward melanocyte extension ends and are transferred from strata basale 
to the strata spinosum epidermal layer. The melanin granules migrate into kerotinocytes 
and surround the nuclei protecting it from the harmful effects of the UV radiation. The 
excessive amounts of melanin in kerotinocytes are removed by lysosome, which accounts 
for the disappearance in the upper epithelial layer in the skin. The interaction between 
melanocytes and kerotinocytes, rate of melanin granule formation in melanocytes, 
transfer to kerotinocytes and deposit of melanin granules regulate the skin color 
(Junqueira and Carneiro 2005). 
The inability of keratinocytes to regulate melanocyte growth due to keratinocytes 
loss of control over melanogenesis leads to malignant transformation evident by rapid 
proliferation, loss of dendrite formation and melanoma-associated antigen (MAA) 
expression significant for metastasis and invasion (Shih et al., 1994; Hsu et al., 2000). 
The melanocytes enter the dermis by infiltrating through the basal lamina entering blood 
and lymphatic vessels migrating throughout the body (Junqueira and Carneiro 2005). 
The development of melanoma is categorized into five stages. First, the common 
acquired nevus which is the initial formation of hyperplastic melanocyte lesions. Second, 
dsyplastic nevus is an abnormal mole without a well-defined border that is potentially a 
precursor for cutaneous melanoma. Third, radial growth phase (RGP) primary melanoma 
which is classified as the first malignant stage. At this point cells are restricted to the 
epidermis or locally invasive but do not demonstrate rapid growth or metastatic ability. 
Fourth, vertical growth phase (VGP) primary melanoma lesions, in which melanoma 
cells permeate the dermis and subcutaneous tissue with capability of entering systemic 
circulation. Fifth, metastasis, which is the advance stage of tumor progression (Hsu et 
al , 2002). 
Factors That Influence Melanoma Development 
Numerous factors influence the development of melanoma. The continuous and 
excessive exposure to sunlight over a lengthy period of time can attribute to premature 
aging (wrinkles) and development of basal cell, squamous cell and melanoma skin 
cancers. Such long term exposure from childhood to adulthood can significantly enhance 
the risk of melanoma development (Osterlind et al., 1988). The emission of UV radiation 
from the sunlight penetrates the epidermal layer of the skin that can cause 
deoxyribonucleic acid (DNA) damage in cells (Cifone and Fidler, 1981), immune system 
suppression (Noonan and De Fabo, 1985), and antioxidant inhibition (Fuch et al., 1989). 
UV radiation can also induce mutations in genes that regulate cell growth such as pi 6, a 
tumor suppressor gene important in cell cycle regulation (Ziegler et al., 1994). The loss 
of Langerhan cells, which are vital for initiation and maintenance of specific-T-cell 
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mediated responses in the skin associated with aging, is another factor linked to 
melanoma (Stene et al., 1988). 
Melanoma Statistics 
Skin cancer accounts for over 50% of all cancers. Melanoma is the least common 
skin cancer and accounts for approximately 3% of skin cancers that leads to a substantial 
amount of skin cancer deaths due to highly aggressive metastatic ability. Though non-
melanoma skin cancers such as basal and squamous cell carcinomas are not considered as 
aggressive as melanoma, they can be potentially detrimental and cause disfigurement. 
Melanoma can develop at a younger age than most cancers with about 50% of individuals 
under age fifty-seven. In adolescents between the ages of 15 to 19, 1 in every 15,000 
boys and 30,000 girls will develop melanoma. The rate of incidence is enhanced with 
aging being the highest among individuals in their 80's. Overall melanoma is ten times 
more likely to occur in Caucasians than blacks with a slightly higher incident rate in 
males in comparison to females (American Cancer Society, 2006 and 2008). 
An estimated 62,480 new cases will be diagnosed in 2008 according to the 
American Cancer Society. The number of new cases among white men and women 
increased approximately 6% per year from 1973 until the early 1980's. Nonetheless 
melanoma incident rate has declined since 1981 to less than 3% per year. The increased 
awareness of melanoma, early detection and the wide use of sunscreen as a precautionary 
measure against harmful UV rays are some factors that attribute to this decrease. In 
2008, the American Cancer Society predicts 8,420 individuals will die from melanoma in 
the U.S. though death rate from melanoma has been relatively constant since 1990 for 
Caucasian men and declining since 1988 for Caucasian women. Since 1973, the 
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mortality rate for melanoma has increased by 50%, in which much of the increase has 
been in older people, mostly white men. The 5-year survival rate, stage 0,1, II, III, IV 
melanoma are 97%, 90 to 95%, 45 to 78%, 28 to 70% and 18% respectively (American 
Cancer Society, 2006 and 2008). 
Melanoma Treatments 
Numerous treatment options are available for melanoma. One method is surgical 
removal by simple excision, re-excision if positive skin biopsy confirms melanoma, 
amputation, and lymph node dissection if lymph node biopsy indicates malignancy near 
cancer site (American Cancer Society, 2006). Patients most likely to benefit from lymph 
node removal are those with soft tissue, lymph node, lung, bowel, adrenal and brain 
solitary lesions (Atallah and Flaherty 2005). However, early stage diagnosis and 
treatment reveal the best results. 
Chemotherapeutic drugs, serve as alternative approaches for treatment of 
metastatic malignant melanoma. These drugs interfere with rapidly dividing cells that are 
beneficial for treating cancer cells that has spread throughout the body. Administered 
intravenously or orally, numerous adverse side effects are associated with the treatment 
such as nausea and vomiting, hair loss, loss of appetite, increase infection, peripheral 
neuropathy, ototoxicity and/or fatigue that are dependent upon the dosage of 
chemotherapy administered. The side effects usually subside upon completion of 
treatment (Atallah and Flaherty 2005). 
The classes of drugs generally used in melanoma treatment include (i) alkylating 
agents that induce their cytotoxic effects by alkylating DNA within the nucleus that cause 
cell death include dacarbazine (DTIC), temozolomide, and cisplatin, which destroys all 
stages of the cell cycle and prevents DNA synthesis and function; (ii) plant alkaloid 
vinblastine that disrupts cytoskeleton structure hindering tubulin polymerization and 
mitotic spindle formation and inhibits of mitotic division that results in cell death; and 
(iii) antitumor antibiotics bleomycin that induce single- and double-stranded DNA breaks 
by interacting with DNA and inhibiting DNA biosynthesis (Katzung, 2007). 
Combination of different drug treatments works better than single drug for stage 
IV melanoma (American Cancer Society, 2006). Many combinations of chemotherapy 
drugs are used in metastatic malignant melanoma. The resistance of melanoma cells to 
chemotherapy makes treatment challenging and detrimental. The two most active 
combinations are the four drug combination of cisplastin (DNA alkylating agent), DTIC 
(DNA alkylating agent), bischloroethylnitrosourea (BCNU) and tamoxifen (Darmouth 
regimen) and cisplatin (DNA alkylating agent), vinblastine (mitotic inhibitor) and DTIC 
(DNA alkylating agent) (Atallah and Flaherty 2005). The Darmouth regimen initially 
demonstrated a 43% response rate (Lattanzi et al 1995) however there were no 
differences in overall survival when compared to randomized phase III trial with DTIC 
only (Chapman et al 1999). Another two chemotherapeutic drugs used in combination 
are thalidomide (anti-angiogenenic drug) and temozolomide (alkylating agent). Reports 
indicated that twelve of thirty eight patients responded with one remission and five other 
patients resected free of disease. The median survival was nine months and treatment 
was endurable (Hwu et al, 2003). 
Recently, a new therapeutic approach involving poly(ADP-ribose) polymerase, 
PARP (protein associated with DNA repair) inhibitors, have been introduced into clinical 
trials (Kasper et al, 2007). The application of PARP inhibitors have been used to treat a 
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variety of diseases such as cancer, cardiac infarct, stroke and diabetes (Woon and 
Threadgill, 2005; Graziana and Szabo, 2005). PARP can cause development of 
resistance to chemotherapeutic agents via DNA damage repair and tumor killing effects 
(Kasper et al, 2007). Blocking this protein makes cancer cells more sensitive to chemo 
treatment thus, enhancing effects on tumor (Plummer et al, 2005). The use of this 
inhibitor along with temozolomide are a part of ongoing studies in eighteen patients with 
newly diagnosed or recurrent unresectable stage III of IV melanoma at the MD Anderson 
Cancer Center (Kasper et al, 2007). 
The concept of immunotherapy is another new developing field of interest for 
cancer treatment based on the body's immune system to produce immune responses 
against cancer cells. When foreign materials or pathogen are introduced into the body 
chemical mediators are secreted to induce an immune response. Cytokines includes 
lymphokines, interleukins and interferons which are soluble signaling protein and 
glycoprotein molecules that act as mediators released by activated T-cells to enhance 
amplification of T-cells and destruction of foreign cells. This principle can be applied in 
cancer therapy such that the body's own immune system can increase cytotoxic T-cells 
production against cancer cells. For individuals with advanced melanoma there are 
several types of immunotherapy used. Cytokine (proteins that turn on the immune 
system) production in stage III and IV melanomas have been shown to reduce tumors in 
about 10 to 20% of patients, however adverse effects include fluid build up that results in 
swelling thus makes a person feel sick (Kasper et al; 2007). There is ongoing 
combination cytokine therapy research for treating advanced stage melanoma in patients 
though toxicity poses an obstacle to overcome (Kalaaji, 2007). 
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Cytotoxic T lymphocyte-associated protein 4 (CTLA) is another target. The 
presence of self-antigen on tumors cells makes tumor removal ineffective by the immune 
system hence development of therapeutic strategies involving tumor immunity becomes 
difficult (Kasper et al; 2007). Studies by Kapadia and Fong (2005) suggest T cells are 
essential in inducing tolerance and reducing immune responses to tumor antigens by 
producing CLTA-4. Such findings have lead to the development of antibodies blocking 
CLTA-4 and clinical trials (Kasper et al 2007). Other reports have indicated the 
inhibition of T cells by CLTA-4 in immune response (Chambers et al, 2001) whereas, 
blockage of CLTA-4 increase T cell responses and tumor rejection (Leach et al 1996). 
The combination of CLTA-4 blockade and tumor vaccination can further improve 
antitumor activity (Hurwitz et al, 2000). Such findings have lead to the development of 
antibodies against CTLA-4 and the start of clinical trials. 
Heat shock proteins serve numerous functions including mediation of apoptosis, 
proteasomal destruction, interaction with other proteins and immunological properties 
(Blachere and Srivastava 1995). The injection of heat shock protein modulators, HspPC-
96 in metastatic melanoma patients demonstrated a tolerance to vaccine with minimum 
toxicological effects in 18% of patients (Pillia et al 2005). However, making a vaccine 
against tumors such as melanoma is more difficult than making a vaccination to fight a 
virus. 
Other quasi-immune alternative methods in the treatment of malignant melanoma 
include antiangiogenic drugs, such as the humanized antibody bevacizumab (Avastin) 
directed against vascular endothelial growth factor (VEGF) and Bcl-2 antisense 
compound. One such drug is oblimersen which reduces Bcl-2 anti-apoptotic protein in 
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combination with chemotherapeutic agents, dacarbazine (DNA alkylating agent), 
paclitaxel (mitotic inhibitor) or interferon (Kasper et al, 2007). The results from ongoing 
trials are not known yet. Targeting RAF proteins associated with the mitogen-activated 
protein kinase (MAPK) signal transduction pathway which are involved in regulation of 
cell proliferation, differentiation and survival serve as another approach. Treatment of 
melanoma with compound sorafenib (BAY 43-9006, Nexavar) not only inhibits C-RAF 
and VEGFR, but also targets B-RAF, which has been implicated to be an important target 
in melanoma to induce apoptosis (Panka et al 2006). Some preclinical trails have 
implicated treatment with the proteosomal inhibitor bortezomib to be active against 
melanoma. Proteosome inhibition can enhance alterations in pro-apoptotic activities 
thereby increasing the sensitivity to immune effector cells (Markovic et al 2005). 
Another melanoma cancer treatment includes radiation. Radiation therapy utilizes 
high energy rays or other ionizing radiation types to reduce or prevent tumor 
development. Radiation can be applied externally or internally where radioactive 
substances are contained within needles, seeds, wires, or catheters positioned directly into 
or close by tumor site. Though this is an uncommon method of treatment for melanoma 
patients, ionizing radiation can be used for a tumor that has returned in the skin or lymph 
node that cannot be removed surgically (Corry et al., 1999). 
Mechanisms of Programmed Cell Death 
Two types of programmed cell death (PCD) include apoptosis (type I) and 
autophagy (type II). Both involve an intracellular program that leads to cell death. The 
term "apoptosis" (Greek origin meaning falling or dropping off) is defined as a form of 
programmed cell death. Many observations since the mid-nineteenth century has shown 
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the importance cell death plays in physiological processes of multicellular organisms, 
such as in embryological development and metamorphosis (Glucksmann, 1951; 
Lockshin, 2001). The term "programmed cell death" was initially introduced in 1964 
(Locksin, 1964), however the morphological processes that resulted from cellular 
destruction were first defined in publication by Kerr et al., in 1972. Apoptosis is 
characterized by several morphological changes including cell shrinkage and 
condensation, DNA fragmentation, cytoskeletal collapse, disassembly of the nuclear 
envelope, externalization of phosphatidylserine, and biochemical changes such as caspase 
activation, changes in pro- and anti-apoptotic protein levels and cytochrome c release 
from the mitochondria. Although the presence of many of these hallmark indicators can 
suggest an apoptotic type of cell death, there are different pathways defined that may or 
may not include each apoptotic event. 
The induction of apoptosis can occur via three well-characterized pathways, 
intrinsic, extrinsic or perforin/granzyme. The distinction among these three relies in part 
on the difference in activated enzymes and proteins that participate in the degradation of 
the cell. Caspases are intracellular proteolytic enzymes that exist as inactive zymogens. 
These enzymes are an essential component of apoptosis responsible for the breakdown of 
cellular proteins. Various triggers can lead to their activation, which usually occurs 
through proteolytic processing of the zymogen at conserved aspartic acid residues. The 
caspases initially involved in the apoptotic process are known as "initiators" (-8, -9, and 
10) that cleave and activate executioner caspases (-3, -6 and -7) that induce cell death 
(Elmore, 2007). 
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The intrinsic pathway becomes activated in response to intracellular stresses 
such as DNA damage, serum deprivation, or stress to endoplasmic reticulum (Adams, 
2003; Aoki, 1996). These stimuli elicit alterations in the mitochondrial membrane that 
cause mitochondrial permeability transition pore (MPT) opening and loss of 
mitochondrial transmembrane potential (AYm) that leads to the release of two main 
groups of pro-apoptotic mitochondrial proteins. The first group include cytochrome c, 
second mitochondria-derived activator of caspase (Smac), direct IAP-binding protein 
(DIABLO), and serine protease HtrA2/Omi (Elmore, 2007). The loss of A1?™ and pore 
openings in mitochondrial membrane results in the release of mitochondrial protein 
cytochrome c, a soluble protein localized in intermembrane space loosely attached to the 
inner mitochondrial membrane. In the cytosol, the interaction of cytochrome c, adaptor 
protein, apoptosis-proteases-activating-factor-1 (APAF-1) and procaspase -9 in the 
presence of dATP forms an apoptosome. This proteolytically activates caspases -9 then -
3 to execute apoptotic death by digesting essential cellular proteins such as activation of 
DNA degrading enzyme DNAse via cleavage resulting in DNA fragmentation (Albert, 
2002; Jacobson and McCarthy, 2002). The Smac/DIABLO and HtrA2/Omi 
mitochondrial proteins interact with apoptosis inhibitory proteins (IAP) to neutralize anti-
apoptotic activity and induce cell death (Hengartner, 2000; van Loo et al., 2002; 
Schimmer, 2004). 
The second group of pro-apoptotic mitochondrial proteins consists of apoptosis 
inducing factor (AIF), endonuclease G and caspase activated DNase (CAD) that are 
released in the late apoptotic phase once the cell death is evitable. These proteins 
translocate to the nucleus and initiate oligonucleosomal DNA fragmentation and 
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enhanced chromatin condensation. Both AIF and endonuclease G function independently 
of caspase activation whereas CAD requires initial cleavage by caspase-3 which results in 
oligonucleosomal DNA fragmentation (Elmore, 2007). 
The Bcl-2 family of proteins plays a critical role in the control and regulation of 
the mitochondria involvement in the stress-induced apoptosis process (Elmore, 2007). 
This family of pro- and anti- apoptotic proteins are categorized into three subfamilies 
based on sequence and protein function: (i) Bcl-2, anti-apoptotic proteins that exert cell 
death activity and shared sequence Bcl-2 homology (BH) within four regions. Examples 
include Bcl-2, BC1-XL, and Bcl-w; (ii) Bax, pro-apoptotic proteins that have homology 
only within BH 1 to 3 and not 4 region and includes Bax, Bak, and Bok; and (iii) BH3-
only, which are pro-apoptotic proteins that share sequence homology only within BH3 
such as Bik, Bid, Bad, Bim, p53 upregulated modulator of apoptosis (PUMA) and Noxa 
(Bouillet and Strasser, 2002; Jacobson and McCarthy, 2002). The sensitivity of cells to 
apoptotic stimuli can depend on the balance between pro- and anti- apoptotic Bcl-2 
proteins. The increase in pro-apoptotic protein levels such as Bax and Bid disrupts the 
normal function of the anti-apoptotic Bcl-2 proteins that leads to the loss of A ^ and 
pore formation in the mitochondria. It has been proposed that Bax forms a 
transmembrane pore in the outer membrane of mitochondria, resulting in the loss of 
membrane potential and cytochrome c release (Albert, 2002; Jacobson and McCarthy, 
2002). Under non-apoptotic conditions, the overexpression of anti-apoptotic proteins, 
Bcl-2 and BC1-XL regulate cell death induction by inhibiting cytochrome c release from 
the mitochondria and pro-caspase-9 activation (Elmore, 2007). 
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While other Bcl-2 family members play roles in both the intrinsic and extrinsic 
pathways, Bcl-2 family members of the pro-apoptotic proteins, PUMA and Noxa are 
primarily associated with the intrinsic pathway. The DNA damage that initiates 
apoptosis usually requires tumor suppressor gene p53, which activates gene transcription 
that encodes a protein to promote cytochrome c release. Both activation of PUMA and 
Noxa are triggered by p53 as a result of geno-toxic damage or oncogene activation 
(Elmore, 2007). PUMA induces ap53 mitochondria dependent apoptotic pathway 
together with enhanced Bax expression that causes cytochrome c release and subsequent 
caspase -9 and -3 activation, respectively (Nakano and Vousden, 2001; Liu et al, 2003). 
Noxa on the other hand, localize to mitochondria also mediates p53 apoptotic induction 
by caspase -9 activation (Oda et al., 2000). 
The extrinsic signaling pathway operates through death receptors (Fas, tumor 
necrosis factor (TNF), TNF- apoptosis inducing ligand (TRAIL) of the tumor necrosis 
factor (TNF) superfamily and their corresponding signaling molecules, ligands (TNF, 
FasL, and TRAIL). TNF-R1 family of receptors can interact with one or more ligands 
that bind with type II transmembrane receptors either soluble or membrane bound. 
Ligand trimerization occurs initially to facilitate ligand interaction and activation of 
receptor that induce cell death, proliferation or differentiation (Jacobson and McCarthy, 
2002). 
The extrinsic pathway consists of a mitochondrial-independent (type I) and 
mitochondrial-dependent (type II) apoptotic induction. The extrinsic type I pathway is 
initiated by activation of the death receptors and their death ligands. The death domain of 
the death receptor recruits death adaptor proteins (Fas-associated protein with death 
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domain, FADD or TNF receptor-death domain, TRADD) along with pro-caspase-8 
enzyme and forms the death inducing signaling complex (DISC). The cleaved active 
caspase-8 fragment then activates caspase -3. This apoptotic pathway can be inhibited by 
c-FLIP (cellular FLICE-like inhibitory protein) by blocking activation of caspase -8 
thereby preventing caspase -8 recruitment to DISC (Thome et al., 1997; Irmler et al, 
1997). The extrinsic type II pathway utilizes death receptors, however, caspase -8 
cleaves pro-apoptotic protein BID which acts on the mitochondria to release cytochrome 
c thus activating caspase -9 then -3. Thus the intrinsic and extrinsic mechanisms are not 
independent and are connected as indicated by the role oft-Bid. 
Ultimately, both the intrinsic and extrinsic apoptotic pathways lead to the 
activation of executioner caspases -3, -6 and -7 that are essential for executing the final 
apoptotic phase. At this stage cell death is inevitable demonstrated by morphological 
changes distinct for the classification of apoptosis. Caspase -3 plays a major role in 
mediating proteolysis of numerous substrates involved in triggering endonucleases and 
cytoskeleton breakdown. Caspase -3 is correlated with the activation of caspase activated 
DNase (CAD) endonucleases responsible for DNA fragmentation by cleaving inhibitor 
segment of the inhibitor caspase activated DNase (ICAD). The disruption of nuclear and 
plasma membrane associated cytoskeleton proteins, fodrin, vimentin, lamin A and 
gelsolin essential for actin filament assembly along with cleavage of substrates, poly 
(ADP-ribose) polymerase (PARP) involved in DNA repair mechanism, signal transducers 
and activators of transcription protein-1 (STAT1) and X-linked inhibitor of apoptosis 
protein (X-IAP) are also targeted by executioner caspase -3 to complete apoptosis (Slee 
et al, 2001; Martin et al., 1995; Elmore, 2007). 
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The perforin/granzyme pathway is another apoptotic pathway utilized mainly by 
cytotoxic T lymphocytes (CTLs) by way of the extrinsic pathway and FasL/FasR 
interaction. CLTs elicit cytotoxic effects to destroy tumor and virus-infected cells 
through perforin (transmembrane-pore forming molecule) secretion in conjunction with 
cytoplasmic granules release through the pore and into target cell. These cytoplasmic 
granules consist of two important serine proteases granzyme A and granzyme B. 
Granzyme B operates by cleavage of proteins at aspartate residues that lead to 
procaspase-10 activation that can cleave ICAD which results in DNA fragmentation or 
through a mitochondrial apoptotic pathway via Bid cleavage that induce cytochrome c 
release followed by caspase activation or directly to activate caspase -3 (Barry and 
Bleackley, 2002; Russell and Ley 2002). 
Granzyme A is an essential part of CLT induced cell death mechanisms that 
activate caspase independent pathways. This protease enters the cell and trigger DNA 
fragmentation via DNAse NM23-H1, a tumor suppressor gene product associated with 
apoptosis induction in cancer tumor cells. Granzyme A interacts with nucleosome 
assembly SET complex of proteins which includes SET, Apel, pp32 and HMG2 that 
inhibit NM23-H1. The activation of NH23-H1 occurs via granzyme A protease cleavage 
of SET complex and NM23-H1 releasing NM23-H1 that leads to DNA degradation and 
apoptosis. The SET complex has additional functions that involve chromatin and DNA 
structure protection however inactivation of complex blocks DNA maintenance and 
chromatin structure that attributes to apoptosis (Elmore 2007). 
Autophagy, is another form of programmed cell death (PCD) by which cells 
recycle cytoplasm and dispose of defective organelles. This type of PCD is 
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characterized by autophagic vacuole (AV) formation that result in intracellular organelle 
(Golgi apparatus, polyribosomes and endoplasmic reticulum) destruction preceding 
nuclear collapse (Bursch et al., 1996). The maintenance of cytoskeletal structure is vital 
for this process to occur. Death-associated protein (DAP)-kinases and related protein 
kinase (DRP-1) are major regulators in autophagic PCD through enhancement of the 
mitochondrial membrane permeabilization. These kinases can also be involved apoptotic 
PCD responsible for membrane blebbing (Bursch, 2004). 
Mechanism of Non-Programmed Cell Death 
Non-programmed cell death mechanisms that differs significantly from PCD type 
I and type II include necrosis. Necrosis is a form of cell death primarily linked to 
inflammatory responses. Cells undergoing necrosis release their intracellular contents 
into the extracellular environment due to the loss of plasma membrane integrity which 
initiates an inflammatory response. Typical morphological characteristics are swelling of 
cells, loss of membrane integrity and cell lysis (Proskuryakov et al., 2003). Necrotic cell 
death can be induced by various viruses, bacteria and protozoa which can activate 
bacterial toxins, and component of the immune defense such as complement, activated 
natural killers and peritoneal macrophages (Warny et al., 2000; Dong et al., 1997; 
Shimizu et al , 2000; Blom et al., 1999; Arantes et al, 2000). 
Importance of Apoptosis in Cancer Treatment 
The induction of apoptosis is involved in many important biological processes. 
One such process includes reproductive organ development that differs for males and 
females. During embryonic development for example, the Mullerian duct forms the 
uterus and oviduct in females however these organs are not developed in males and are 
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removed by apoptosis (Meier et al., 2000). Another example is lymphocyte development, 
maintenance of homeostasis and disease. Increase apoptotic induction in lymphocytes 
can lead to immunodeficiency whereas inhibition can cause autoimmunity or lymphoma 
(Rathmell and Thompson, 2002). Also elimination of damaged and harmful cells, such 
as irreparably DNA-damaged cells, autoreactive cells, and infected cells (Gewies, 2003). 
On the other hand, dysfunctions in the apoptotic pathway have been associated 
with numerous pathological conditions. Such mutations or defects can result in cancer, 
autoimmune diseases and the spreading of viral infections whereas excessive apoptosis 
can cause neurodegenerative disorders, AIDS, and ischemic diseases (Reed, 2002; 
Fadeel, 1999). Mutations in apoptotic pathway has also been implicated in plant biology 
by activation cysteine proteases (Solomon, 1999) and yeast (Frohlich, 2000; Skulachev, 
2002). 
Mutations in the apoptotic pathway have been associated with tumorigenesis and 
progression, metastasis, and development of resistance to chemotherapeutic drugs 
(Johnstone et al., 2002). The development of mutations in adaptor protein APAF-1, RAF 
family of protein BRAF, tumor suppressor gene PTEN and cyclin-dependent kinase 
family CDK4 have been associated with melanoma (Haluska et al., 2006). The 
downregulation of pro-apoptotic protein PUMA and upregulation of apoptotic inhibitors 
survivin and FLIP can attribute to this phenomenon (Irmler et al., 1997; Grossman et al., 
1999; Soengas et al., 2001; Karst et al., 2005). The proliferation rate of tumor 
development is not merely due to oncogene activation but impairment of apoptosis 
checkpoint (Hanahan and Weinberg, 2000; Wang, 1999). Therefore providing 
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appropriate treatment conditions to inhibit or activate pro- and anti-apoptotic proteins can 
provide effective treatment in cancer treatment. 
Agents That Induce Apoptosis in B16F10 Melanoma Cells 
Many compounds have demonstrated different mechanisms in the induction of 
apoptosis in B16F10 melanoma cells. Capsaicin which is a pungent ingredient found in 
hot chilli peppers that have been noted for its anticarcinogenic and antimutagenic 
activities. This compound was reported to inhibit growth and induce apoptosis marked 
by nuclear condensation, internucleosomal DNA fragmentation, enhanced sub Gl 
fraction, cytochrome c release, caspase -3 activation and cleavage of poly (ADP-ribose) 
polymerase. Though Bcl-2 level were slightly down regulated, no changes in Bax levels 
were detected (Jun et al., 2007) 
Aspirin (salicylate and acetyl salicyclic acid) was revealed to reduce B16F10 
melanoma cells proliferation rate dependent on c-Jun N-terminal kinase (JNK) (Ordan et 
al 2003). The extracellular matrix (ECM) is known to be essential in the survival and 
metastasis of cancer cells. Treatment of B16F10 cells with methylselenol disrupted 
integrin expression and ECM adhesion through a caspase induced cell death mechanism 
(Kim et al., 2007). Also vitamin C was shown to stimulate a caspase -8 independent 
apoptosis by phosphatidylserine externalization, enhanced levels of reactive oxygen 
species (ROS), decrease in mitochondrial membrane potential and cytochrome c release 
(Kang et al., 2003). 
Blood supply is essential in tumor development. The use of angiogenic inhibitors 
can be beneficial in cancer therapy as the formation of new blood vessels is required for 
development. The angiogenesis inhibitor, TNP-470, induced cell death two hours post 
treatment without typical apoptotic morphological changes identified, however reactive 
oxygen species (ROS) were generated (Okroj et al., 2005). Another study investigated 
further the effects of TNP-40 in B16F10 melanoma cells. The results demonstrated 
uncharacteristic cell death, with no phosphatidylserine externalization but membrane 
permeability indicated by propidium iodide uptake. No mitochondrial transmembrane 
potential changes detected and no effect of the panspecific caspase inhibitor (Okroj et al., 
2006). 
Electric Field Application in Cancer Treatment 
The application of electric fields to mammalian cells is currently being used in 
cancer therapy. Convectional electroporation has been around for decades and 
electroporation is an alternative approach considered in cancer treatment. This method 
delivers long electrical pulses ranging from milliseconds to microseconds that enhances 
ion conductance across the plasma membrane through creating large pores (Weaver, 
1995). The application of electric pulses, permeabilize cells that facilitate the entry of 
DNA, RNA, drugs and proteins into the cells. The basis of this method has lead to the 
incorporation with other therapeutic techniques to enhance the efficacy of cancer 
treatment and chemotherapeutic drugs. Electrochemotherapy (ECT) is one such method 
that incorporates the application of both electric fields and chemotherapeutic drugs by 
introducing drugs into the cell and enhancing therapeutic effects. The application of ECT 
was demonstrated in combination with chemotherapeutic drug bleomycin that resulted in 
tumor reduction in mice (Mir et al., 1991a). The results of this study lead to ECT 
treatment in combination with bleomycin clinical trials that was effective in treatment of 
head and neck squamous carcinomas in patients (Mir et al., 1991b). 
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Belehradek et al. 1993 demonstrated effective treatment initially in melanomas 
ECT with bleomycin on cutaneous metastases of head and neck carcinoma patients. 
Early clinical trials by Heller et al. 1996 used ECT with bleomycin in treatment of 
malignant melanoma, two with basal cell carcinoma, and one with metastatic 
adenocarcinoma. The most effective response was demonstrated in adenocarcinoma with 
complete responses in both treated nodules after ECT. The application with bleomycin 
has been successful in the treatment of cutaneous, subcutaneous and perineal malignant 
tumors. The introduction of chemotherapeutic drugs into tumor cells, such as bleomycin, 
has demonstrated beneficial results in the treatment of melanoma tumors (Kubota et al, 
2005; Gothelfetal, 2003). 
ECT technique has been implicated to enhance the efficacy of immunotherapeutic 
drugs in cancer treatment. The amplification of cytokines, more specifically interleukins 
in combination with electroporation can potentially serve an alternative approach for 
melanoma treatment. Study by Dev and Hofmann, 1994 initially paved the way for this 
approach illustrating the amplification of interleukin-2 (IL-2) in effective treatment of 
squamous cell carcinomas of the head and neck in animals and patients. More recent 
report in B16 mouse melanoma demonstrated interleukin-12 (IL-12) plasmid delivery 
along with electroporation reduce tumor revealing minimum adverse side effects 
associated with it (Heller et al., 2006). 
Irreversible electroporation is another procedure involving electrical fields that 
can be potentially used on tumor treatments. Such application involves permanent 
permeabilization of the membrane that alters cell homeostasis that leads to cell death 
(Rubinsky, 2007). The potential application of irreversible electroporation treatment has 
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been highlighted in liver cancer and prostate cancer though scarring from ablated area 
results due to heating (Lee et al., 2007; Onik et al., 2007). Radiofrequency thermal 
ablation (RFA) is somewhat new treatment approach that produces alternating currents 
that generates ionic agitation that leads to frictional heating to destroy tumors. Numerous 
types of carcinomas (renal, hepatic, prostate, bone and others) have been treated by RFA 
however optimal results have been demonstrated in breast cancer patients (Fornage et al., 
2004; Vlastos and Verkooijen HM, 2007). Though all previously described electrical 
pulse applications demonstrate an effective means of carcinoma treatment, they all 
generate heat that cause tissue damage and scarring to ablated area. For both irreversible 
electroporation and radiofrequency ablation the mechanism for tumor death is necrosis. 
Advantage of New Nanosecond Pulsed Electric Fields (nsPEF) Treatment 
The application of nsPEF differs from classical electroporation which has longer 
pulse durations (milli- to micro-second) with charging time of the plasma membrane as 
oppose to shorter durations of nanosecond pulses that generates pulses with high-
intensity electric fields (Beebe et al, 2003a). Unlike electroporation, these nanosecond 
pulses deliver high electric field intensity (kV/cm) and high power (megawatts) but low 
energy density (mJ/cc) (Hall et al, 2005) which generates little heat. Also in contrast to 
electroporation, which produces large pores in the plasma membrane that permit entry of 
large molecules, drugs or genes, nsPEFs produce large number of nanopores that limit 
entry to ions but not drugs or genes. The field can penetrate into the cell permeabilizing 
intracellular organelles (Schoenbach et al, 2001) and mobilizing calcium (White et al, 
2004; Beebe et al, 2003b; Vernier et al, 2003; Vernier et al, 2006). These ultra-short 
pulses can act as non-ligand agonists that induce cell signal transduction mechanisms that 
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induce apoptosis by affecting intracellular and plasma membrane structures and 
functions. Reports in Jurkats have illustrated that nanosecond pulses induce direct 
electric field and biological effects that initiate apoptosis and caspase activation as 
indicated in Jurkats and HL-60 cells (Beebe et al, 2003a). Electric field target 
intracellular organelles that subsequently lead to apoptosis induction in vitro (Beebe et al, 
2003b). DNA fragmentation (Stacey et al, 2003; Hall et al., 2007) and reduced effects on 
the plasma membrane with enhanced functions on intracellular structures has also been 
demonstrated with nsPEF application (Schoenbach et al, 2001; Beebe et al 2003a). 
However, it is interesting that nsPEFs induced apoptosis in p53 null and wildtype HCT 
116 cells, suggesting that if DNA is damaged, p53 does not play a role. 
Other advantages of nsPEFs have been demonstrated in tumor reduction (Beebe 
et al 2002; Nuccitelli et al., 2006). The study in B16F10 mouse melanoma tumor suggest 
that nanosecond pulses induce apoptosis and tumor regression generating little to no 
thermal buildup and require no administration of chemotherapeutic agents, which reduces 
adverse side effects induce by chemotherapy. Furthermore the blood supply to the tumor 
is reduced and there is reduced/no scarring potential as opposed to the surgical skin lesion 
removal that leaves skin scars. NsPEFs are minimally invasive and are more likely to 
affect the tumor without disrupting the dermis (Nuccitelli et al, 2006). Though results of 
this study are promising for nanosecond pulses as an alternative cancer therapeutic 
approach, however, it will be important to determine the cell death mechanism(s) 
associated with this observation, which require additional studies and are addressed in 
this dissertation. Although other studies have implied activation of multiple apoptotic 
pathways induced by nsPEFs in different cell types (Beebe et al., 2003a; Hall et al., 
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2007), this thesis will demonstrate the induction of multiple apoptotic pathways induced 
the nanosecond pulses in the a single cell type, B16F10. 
Previous/Current Publications 
Previous work has indicated reduction in fibrosarcoma tumors in mice when 
electric fields are applied (Beebe et al, 2002). Current study from the Old Dominion 
University Frank Reidy Center for Bioelectrics has shown that the administration of 
nanosecond pulsed electric fields reduce melanoma tumors by 90% within two weeks of 
electric field application via restriction of blood supply and reduction in cell nuclei 
(Nuccitelli et al, 2006). Even though a 2.6-fold increase of caspase activity was 
mentioned for B16F10 melanoma tumors, no statistical significant differences were 
detected (Nuccitelli et al, 2006). The stated reason for this finding was that apoptosis is 
an energy-requiring process and restriction of blood does not allow the apoptosis to go to 
completion (Nuccitelli et al, 2006). However, more recent unpublished studies have 
demonstrated that nsPEFs induce increases inn the numbers of apoptotic cells in B16F10 
melanoma tumors in vivo as determined by fluorescent antibodies to caspases-3, -6, and -
7. 
SPECIFIC AIMS 
Specific Aim 1: To determine whether nsPEF stimulation induces apoptosis in 
B16F10 melanoma cells in vitro. 
This aim determined whether nsPEFs induce apoptosis in B16F10 melanoma cells 
in vitro. The first hypothesis was that nsPEFs affect viability/survivability in a time and 
electric field dependent manner. The second hypothesis was that nsPEFs effects 
membrane integrity and phosphatidylserine externalization in an electric field dependent 
time course. The third hypothesis was nsPEFs induce caspase activation in an electric 
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field dependent manner independent of calcium mobilization. The fourth hypothesis was 
nsPEFs induce apoptotic morphological changes such as F-actin cytoskeletal disruption 
and membrane blebbing. 
Specific Aim 2: To establish whether nsPEFs stimulate a mitochondrial-independent 
or -dependent apoptotic pathway 
This aim established whether nsPEFs stimulate a mitochondrial-independent or -
dependent apoptotic pathway. The fifth hypothesis was that nsPEFs induce caspase-
dependent apoptosis in the absence of cytochrome c release, mimicking the type I 
extrinsic apoptosis pathway. The sixth hypothesis was nsPEFs induce activation of 
initiator caspase -8 and executioner caspases -3, -6 and -7. 
SIGNIFICANCE 
The aim of the project is not only to understand how nsPEFs induce cell death and 
the pathway mechanisms by which cells undergo apoptosis in vitro but also to provide an 
understanding for the application of pulse electric fields. Though it is not fully 
understood how these tumor cells undergo cell death, but some melanoma cells are 
known to require calcium and contain mutations in their apoptotic pathway (Niedojadlo 
et al, 2005). Investigation into how nsPEFs induce cell death and the multiple apoptotic 
pathway(s) involved in this process is essential in understanding nsPEFs role in the 
initiation of cell death in these melanoma cells. This can potentially provide an 
alternative non-ligand, non-chemotherapeutic treatment of melanoma tumors (other 
malignant tumors) or an alternative combination treatment that consists of nsPEFs and 
low-dose chemotherapeutic treatment reducing side effects that result from high dose 
treatments. 
CHAPTER II 
NANOSECOND PULSED ELECTRIC FIELDS INDUCE APOPTOSIS 
IN B16F10 MELANOMA CELLS IN VITRO 
INTRODUCTION 
Apoptosis is a form of programmed cell death that is mediated by caspases, a 
family of cysteine proteases. Caspases are intracellular proteases that exist as 
catalytically inactivate zymogens that are required to undergo proteolytic cleavage and 
activation during apoptosis. These enzymes are an essential component responsible for 
apoptosis induction and the morphological changes that lead to cell death. Initially, 
apoptosis induction requires the initiation of cellular events to activate apoptotic 
mechanism such as intracellular stresses, receptor-mediated signals, cytotoxic T cell 
attack or some other inducer. Once cell death inevitably commits to cell death by 
activation of executioner caspases or release of mitochondrial proteins from the 
intermembrane space the cell apoptotic degradation process takes place. This 
degradation event is related to the final removal of the cell, including plasma membrane 
blebbing, cell shrinkage, DNA fragmentation and phosphatidylserine externalization 
(Wilson, 1998; Elmore, 2007). 
Nanosecond pulsed electric fields (nsPEFs) are ultrashort pulses with high electric 
field intensity (kV/cm) and high power (megawatts) but low energy density (mJ/cc) (Hall 
et al, 2005). Previous in vitro studies have implicated these ultra-short pulses induce 
direct and biological effects that initiate apoptosis at the plasma membrane and 
intracellular structures. Studies in Jurkat T lymphoblasts and HL-60 cells illustrated 
nsPEF stimulate effects on the plasma membrane through externahzation of 
phosphatidylserine and enhanced membrane permeabilization (Beebe et al, 2003a; 
Vernier et al., 2004). The identification of intracellular apoptotic proteins, caspase FITC-
VAD-FMK and pro-apoptotic protein BAX have been identified with administration of 
nsPEFs (Beebe et al, 2003a; Vernier et al , 2003; Hall et al., 2007). Such treatment has 
been shown to cause cell shrinkage and DNA fragmentation correlated with apoptosis 
(Stacey et al., 2003; Hall et al., 2007). The effects on intracellular organelles via 
intracellular calcium release have been reported to induce caspase activation that leads to 
cell death (Mattson, 2003). The mobilization of calcium initiated by nsPEFs has been 
shown; however, caspase activation can be dependent and independent of calcium (Beebe 
et al, 2003). 
Previous reports suggest that nsPEFs induce apoptosis in Jurkat T lymphocytes, 
HL-60, HCT 116p(+/+) and HCT116p53(-/-) cells. Here the objective was not solely to 
evaluate apoptosis using standard apoptotic markers to examine plasma membrane and 
intracellular modifications, but also to observe structural morphological changes in the 
plasma membrane and cytoskeleton structure in B16F10 melanoma cells in vitro by way 
of nsPEFs application. This study revealed induction of apoptosis in a pulse number and 
electric field dependent manner, independent of calcium mobilization and 
phosphatidylserine externalization. Administration of treatment also results in disruption 





Mouse melanoma cells (B16F10) used in study was obtained from ATCC (Manassas, 
VA). B16 cells were grown in Dulbecco's Modified Eagle's Medium with L-glutamine 
(ATCC; VA) supplemented with 10% fetal bovine serum (Atlanta Biologicals; Nocross, 
GA), 1% L-glutamine and 1% penicillin streptomycin (Mediatech Cellgro; VA) and 
placed in incubator at 37°C with 5% CO2. 
Cell preparation 
B16F10 cells for treatment were detached from cultured flask when cells are 
about 80-90% confluent. This involves removal of media from flask, a rinse with Hank's 
Balanced Salt Solution IX (Mediatech Cellgro;VA), trypsin EDTA IX 
0.25%trypsin/2.21mM EDTA in HBSS addition (Mediatech Cellgro;VA) and DMEM 
culture medium addition. B16F10 cell preparation prior to pulse involves centrifugation 
at lOOOrpm and addition of Dulbecco's Phosphate Buffered Saline (DPBS) solution 
which contains 0.5mM CaCl2.2H20, 4.2mM KC1, KH2P04, 0.5mM MgCl2.6H20, 
153mM NaCl, 9.5mM Na2HP04.7H20 and 2.5mM glucose, pH 7.4. Cell count 
performed using a hemacytometer, centrifugation at 1000 rpm and DPBS solution 
addition based on 7.7x106cells/mL. 
Administration of nsPEF 
Trypsinized B16 cells 7.7x106cells/mL are exposed to nsPEF conditions at a 
concentration of lxl06cells/130uL placed in 0.1cm gene pulser cuvettes (Bio-Rad 
Laboratories; Hercules, CA). Rectangular high voltage pulses of 300 ns duration and 
amplitudes of 1.2-6.0 kV are applied by transmission line type pulse generator to the 
plane parallel electrodes in the cuvette. Representative pulse shapes are shown in Figure 
1. The 10-Ohm impedance of the pulse generator is matched to the resistance of the 
exposed sample. With increasing voltage, the rise time of the pulses increases slightly 
from 15.3 to 19.1 ns. The applied voltages correspond to homogeneous electric fields of 
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FIGURE 1 Representative graph of voltages applied across B16F10 
melanoma cells ranging 12-60kVcm (recorded with Tektronix 
oscilloscope TDDS32 and Tektronix high voltage probe PA6013). 
Trypan Blue Exclusion at 24hrs 
B16F10 cells were prepared as previously mentioned and were counted using a 
hemacytometer prior pulse administration. After 300ns pulse application, cells were 
transferred from cuvettes into a culture flask with DMEM, 1% L-glutamine and 1% 
penicillin streptomycin and placed in incubator at 37°C with 5% CO2 for 24hrs. Cells 
were detached from the cultured flask as previously mentioned, centrifuged and 
resuspended in DPBS. Cell counts were performed using a hemacytometer diluted with 
trypan blue 24hrs post pulse. 
Assessment of Caspase Activation 
B16F10 melanoma cells were administered one, three and ten 300ns pulses at 12-
60kV/cm in 0.1cm electrode gene pulser cuvettes. Caspase activity was determined with 
a FITC-VAD-FMK (Promega; Madison, MI) fluorescent cell permeable irreversible 
inhibitor that binds to the active site of caspases for twenty minutes prior to completion 
of time course. The cells were washed and re-suspended in DPBS. Fifteen thousand 
cells were acquired by Becton-Dickinson flow cytometer. Data was analyzed by Cell 
Quest Pro software. 
Evaluation of Yo-Pro-1 
B16 melanoma cells were prepared (as mentioned previously) and exposed to ten 
300ns pulses in the presence of 0.2uM Yo-Pro-1 (Invitrogen; Oregon) a carbocyanine 
nucleic acid stains that identifies apoptotic cells while remaining impermeant to 
propidium iodide. Cells were incubated for fifteen minutes, washed, centrifuged and re-
suspended in DPBS solution. The fluorescence intensity measured by a Becton-
Dickinson FACSCalibur flow cytometer acquiring 15,000 cells and data analyzed by Cell 
Quest Pro software. 
Evaluation of Membrane Permeability 
B16 melanoma cells were prepared as mentioned previously and exposed to 
nsPEF conditions in the presence and absence of 1:5 propidium iodide/RNase A staining 
buffer (Invitrogen; Oregon). The fluorescence excitation and emission maximum is 
535nm and 617nm, respectively. Fifteen thousand cells were acquired and red 
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fluorescence analyzed by a Becton-Dickinson FACSCalibur flow cytometer. Data 
analyzed by Cell Quest Pro software. 
Annexin V Binding Examination 
B16 melanoma cells were prepared as mentioned previously. The detached cells 
were exposed to nsPEFs, administered one, three and ten 300ns pulses, centrifuged, re-
suspended in Annexin-V binding buffer followed by Annexin-V-FITC incubation (Alexis 
Biochemical; San Diego, CA). Fifteen thousand cells were analyzed by Becton-
Dickinson FACSCalibur flow cytometer one hour post pulse. Data analyzed by Cell 
Quest Pro software. 
Caspase & Calcium Assessment 
Calcium levels were measured using 5uM Fluo-3AM (Invitrogen; Oregon), a 
fluorescent calcium indicator. B16F10 melanoma cells were pre-incubated with Fluo-
3 AM in the absence and presence of calcium chelators at 20uM BAPTA-AM and ImM 
EGTA for thirty minutes, washed and re-suspended in DPBS with or without calcium in 
ImM EGTA. B16F10 melanoma cells were administered ten 300ns pulses at 12-
60kV/cm in 0.1cm electrode gene pulser cuvettes, washed in re-suspended in DPBS with 
or without calcium in ImM EGTA (5uM concentration of ionomycin was used as 
positive control). Fifteen thousand cells were analyzed by a Becton-Dickinson flow 
cytometer. Data were analyzed by Cell Quest Pro software. 
Caspase activity was determined using a FITC-VAD-FMK indicator (Promega; 
Madison, WI), a cell permeable irreversible inhibitor that binds to the active site of 
caspases. B16F10 melanoma cells were first pre-incubated in the absence and presence 
of calcium chelators at 20uM BAPTA-AM and ImM EGTA for thirty minutes, washed 
32 
and re-suspended in DPBS with or without calcium in ImM EGTA. Cells were 
administered ten 300ns pulses at 12-60kV/cm in 0.1cm electrode gene pulser cuvettes, 
washed in re-suspended in DPBS with or without calcium in ImM EGTA followed by 
incubation with FITC-VAD-FMK indicator for twenty minutes. Fifteen thousand cells 
were analyzed by a Becton-Dickinson flow cytometer. Data were analyzed by Cell Quest 
Pro software (5uM concentration of ionomycin was used as positive control). 
Evaluation of F-actin Cytoskeletal Structure 
Cells were prepared and exposed to nsPEF condition as previously mentioned. 
Cells were fixed according to manufacturer's instructions using fixative from 
Carboxyfluorescien FLIC A Kit (Immunochemistry Technology LLC; Minnesota) for 
fifteen minutes, dried on slides overnight in incubator at 37°C with 5% CO2. Cells were 
permeabilized with 0.2% triton, blocked in 1% Bovine Serum Albumin followed by 
incubation with 6.6uM rhodamine phalloidin (Invitrogen; Oregon) which stains the F-
actin cytoskeleton structure. Slides were cover slipped and mounted with 4, 6-diamidino-
2-phenylindole, dihydrochloride (DAPI) and cytoskeletal structure and nucleus viewed by 
Olympus BX51 microscope and images captured by DP70 camera. 
Detection of Membrane Blebbing 
Slides were prepared as described above for the evaluation of F-actin cytoskeleton 
structure except brightfield images of cells viewed by Olympus BX51 microscope and 
images captured by DP70 camera. 
Statistical Analysis 
Statistical analysis was performed using SigmaPlot software. Non-nominal data 
were compared using two-way ANOVA followed by Bonferroni t-test. This test was 
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used to analyze significant differences in caspase activity between groups pulsed in the 
presence and absence of calcium chelators (Figure 8). Ap value of <0.05 was considered 
significant. 
RESULTS 
NsPEF-induced cell death is correlated with caspase activation in a pulse number-
and electric-field manner in B16 melanoma cells. 
In order to determine if nsPEFs induced apoptosis in B16F10 melanoma cells in 
culture, cells survivability 24 hours post pulse via trypan blue exclusion and caspase 
activity measured by flow cytometry was examined. For one or three pulses at electric 
fields between 12-60 kV/cm there was no significant decrease in cell survival 24 hours 
post pulse (Figure 2A) and no increase in caspase activity (Figure 2B). However, for one 
and three pulses at 40 or 60kV/cm cell numbers did not increase either because the cell 
cycle progression was delayed or the number of cells that divided equaled the number of 
cells that died. When cells were exposed to ten 300ns pulses, decreases in cell survival 
and increases in caspase activation were coincident in an electric field-dependent manner, 
with significant changes in both parameters evident at 40 and 60kV/cm. Caspase 
activation was observed as early as 30 minutes post pulse (data not shown). 
Increases in the nanosecond pulse electric field recruits greater number of cells to 
induce caspase activity. 
Unknown whether nsPEF effects on caspase activity were due to increases in 
activity in sub-population of cells or an increase in the numbers cells expressing activity 
as the electric field increased further evaluations were necessary. To determine this 
B16F10 melanoma cells were exposed to ten 300ns pulses with increasing electric fields 
and the entire population analyzed for the percentage of cells that showed active caspase 
by flow cytometry. The individual panels in Figure 2 representative of a typical 
experiment displayed in histogram illustrate results from a typical experiment showing 
active caspase-negative and caspase-positive cells on the left and the right side of the line 
respectively. As the electric field is increased greater percentages of cells are recruited 
into the caspase-positive population. 
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FIGURE 2 NsPEF-induce cell death is correlated with 
caspase activation in a pulse number- and electric-field 
dependent manner in B16F10 melanoma cells. Panel A: B16 
melanoma cells were exposed to one (n=3), three (n=3) and 
ten (n=5) 300ns pulses ranging from 12-60kV/cm and 
survivability was assessed by trypan blue exclusion 24 hours 
post pulse. Panel B: Active caspase fluorescence intensity is 
indicated as cell percentage measured using a FITC-VAD-
FMK In Situ Marker 2 hours post pulse (n=3). Cells were 
analyzed by flow cytometry 2 hours post-pulse. 
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FIGURE 3 Nanosecond Pulsed Electric fields enhance caspase activation an 
electric field dependent increment. B16F10 melanoma cells exposed to nsPEFs previously mentioned 
or 200 uM phloretin for one hour and caspase activity measured using a CaspACE™ FITC-VAD-
FMK In Situ Marker 2 hours post pulse or n=3. Cells were analyzed by flow cytometry. 
The uptake of Yo-Pro-1 is correlated with the activation of caspase in an electric 
field-dependent manner. 
Short pulse durations with rapid rise-times have lesser effects on the plasma 
membrane and greater effects in intracellular membranes (Beebe et al, 2003b). Yo-Pro-1, 
is a unique indicator because it has the capability of identifying cells undergoing 
apoptosis while remaining impermeant to membrane integrity marker propidium iodide. 
This marker was used as an additional indicator for identifying apoptotic induction 
induced by nsPEFs correlated with caspase activation. The results indicate that nsPEFs 
induce apoptosis in B16F10 melanoma cells in an electric field dependent manner linked 
to caspase activation in the same manner (Figure 4). 
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FIGURE 4 NsPEFs enhance Yo-Pro and caspase activation 
in an electric field dependent manner. B16F10 melanoma 
cells exposed to ten 300ns pulses ranging from 12-60kV/cm 
in the presence of Yo-Pro-1 (n=7). Cells were pre-incubated 
with FITC-VAD-fmk (n=7) for 20 minutes and washed. 
Cells were analyzed by flow cytometry 30min post pulse. 
NsPEFs effects membrane permeability in a pulse number and electric field 
dependent manner. 
Pore formation in the plasma membrane can attribute to cell death or lead to 
apoptosis induction. NsPEFs can have effects on the plasma membrane that may 
potentially be one contributing factor. Experimental data in Figure 5 suggest no 
significant effect on membrane permeability with one and three pulses at various electric 
fields. However, measured 30 minutes post-pulse, membrane permeability was not 
affected until cells were exposed to ten 300ns pulses at 40 or 60kV/cm when there was a 




FIGURE 5 NsPEF effects membrane permeability determined by propidium iodide fluorescence 
intensity and cell percentage uptake. B16F10 melanoma cells were exposed to one, three and ten 300ns 
pulses ranging from 12-60kV/cm or 200uM phloretin (PHL) for 30min in the presence of propidium 
iodide. The percentage of cells exhibiting propidium iodide uptake in Panel A and the fluorescence 
intensity indicated by the geometric mean in Panel B were measured by flow cytometry 30min post 
pulse (n=3). 
NsPEFs enhance membrane permeability in B16F10 melanoma cells in a time 
dependent manner. 
In Figure 5, the effects nsPEFs have on membrane permeability in a pulse number 
and electric field dependent manner was examined. In order to identify the time at which 
the membrane permeability becomes comprised and the duration of pore opening, a sixty 
minute time course at one, three, five, ten, fifteen, thirty and sixty minute intervals was 
carried out. Data indicated in the first three minutes post pulse no significant difference 
in the percentage of cells (Figure 6B & 6D) or in the mean fluorescence (Figure 6A & 
6C) were observed for PI uptake into the cells. However, there was a time-dependent 
increase in PI uptake reaching a maximum cell percentage and mean fluorescence 15 
minutes post-pulse. Cells administered pulse in the presence of propidium iodide 
38 
illustrated a greater percentage cells that take up propidium iodide, (Figure 6D) than cells 
treated in the absence of propidium iodide (Figure 6B). 




























FIGURE 6 NsPEFs effects membrane permeability in an electric field and time dependent manner. 
B16F10 melanoma cells were exposed to ten 300ns pulses at 60kV/cm in the presence and absence of 
propidium iodide or 200uM phloretin (PHL) for one hour. The uptake was measured at times l-60min by 
flow cytmetry (n=3). Panel A & C: propidium iodide uptake cell percentage and Panel B & D: propidium 
iodide fluorescence intensity geometric mean. 
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NsPEFs has minimal effects on phosphatidylserine(PS) externalization. 
Another membrane marker used to examine nsPEF-induced effects was Annexin-
V binding as a measure of PS externalization, which is a membrane indicator that 
identifies apoptotic cells. To determine effects of nsPEFs on membrane PS orientation, 
B16F10 melanoma cells were exposed to ten 300ns pulses and Annexin-V-FITC binding 
was determined by flow cytometry analysis lhr post pulse. Data indicated that 
membrane integrity determined by PI uptake becomes comprised in less than 40% of 
cells in an electric field dependent manner (Figure 6B). However, under these conditions 
there are no significant effects of nsPEFs on PS externalization (Figure 7). 
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FIGURE 7 NsPEFs has minimal effects on phosphatidylserine externalization. B16F10 melanoma 
cells were exposed ten 300ns pulses at 60kV/cm or 200 uM phloretin (PHL) for one hour and 
Annexin V (human recombinant FITC) added prior to flow cytometry analysis lhr post pulse. Panel 
A demonstrates the percentage of cells that exhibit phosphatidylserine externalization via Annexin V 
binding and Panel B displays the fluorescence intensity indicated by the geometric mean (n=3). 
NsPEF induce caspase activation in an electric field dependent manner independent 
of calcium mobilization. 
Elevated intracellular calcium levels have been reported to induce caspase 
activation that leads to apoptosis (Mattson, 2003). In parallel experiments, calcium levels 
were determined in Fluo-3-AM loaded B16F10 cells (Figure 8A) and caspase levels were 
determined using FITC-VAD-FMK (Figure 8B) in the presence and absence of 
intracellular BAPTA-AM and extracellular EGTA. Ionomycin increased calcium 2-fold 
above basal levels, but no significant increases were observed in response to nsPEFs. 
The chelators decreased calcium 4-5-fold below basal levels to nearly undetectable 
quantities. When the chelators were present during nsPEF application, electric field-
dependent increases in caspase activation was revealed with significant difference at 
60kV/cm. This suggest that at 60kV/cm, calcium may potentially have an inhibit effect 
on caspase activation. 
NsPEF disrupt cytoskeletal structure in B16F10 melanoma cells. 
Caspase proteases are known to be involved in many morphological changes that 
initiate programmed cell death, one of which is alterations in the cytoskeleton structure 
(Slee et al., 2001; Elmore, 2007). Microscopy photographs, in Figure 9 illustrate the 
disruption of the F-actin cytoskeletal structure when ten 300ns pulses are applied at 
60kV/cm 2 hrs post pulse, whereas cells not exposed to pulse conditions (OkV/cm) and 
anticancer agent phloretin maintains its F-actin cytoskeletal integrity; evident by number 
of nuclei that does not have F-actin associated with it in comparison to non-treated and 
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FIGURE 8 NsPEFs induce caspase activation independent of 
calcium mobilization. B16F10 melanoma cells were exposed ten 
300ns pulses with electric fields ranging from 12-60kV/cm. The 
cells were pre-incubated in the presence and absence calcium 
chelators, BAPTA-AM and EGTA followed by incubation with 
calcium indicator, Fluo-3-AM and apoptotic marker FITC-VAD-
FMK and analyzed via flow cytometry 30min post pulse in parallel 
experiments (n=4). Both Panel A and B represents the fluorescence 
intensity of the respective indicators Fluo3-AM and FITC-VAD-
FMK indicated as the geometric mean, (positive control: 200uM 
phloretin). Panel B: +BAPTA-AM & EGTA Group significant 
difference with 60kV/cm vs. ionomycin and 0-40kV/cm & 
40kV/cm vs. ionomycin & 0-18kV/cm; -BAPTA-AM & EGTA 
Group significant difference with 60kV/cm & 40kV/cm vs. 0 and 
12kV/cm. Significant difference between +/-BAPTA-AM & 
EGTA Group at 60kV/cm (P<0.05). 
Rhodamine Phalloidin Both 
FIGURE 9 NsPEFs disrupt cytoskeleton structure. B16F10 melanoma cells were exposed to ten 
300ns pulses at 60kV/cm or 200uM phloretin for two hours. Cells were fixed two hours post pulse, 
dried in an incubator at 37°C overnight, stained with rhodamine phalloidin, mounted with DAPI 
(bluemucleus), cover slipped and viewed by an Olympus BX51 microscope and cells were captured 
with a DP70 camera. 
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NsPEF induce membrane blebbing. 
Apoptosis is also characterized by bleb formation. Brightfield micrscopy images 
displayed irregular budding-like structures typical of blebbing when exposed to ten 300ns 
pulses at 60kV/cm two hours post pulse in comparison to OkV/cm condition where cells 
reveal a more spherical structure. 
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FIGURE 10 NsPEFs induce membrane blebbing. B16F10 melanoma cells were exposed 
to ten 300ns pulse at 60kV/cm or 200uM phloretin for two hours. Cells were fixed two 
hours post pulse, dried in incubator at 37°C overnight, stained, mounted with DAPI 
(blue:nucleus), cover slipped and viewed by an Olympus BX51 microscope and 
brightfield images captured with a DP70 camera. (A). Cell treated with phloretin (B). 
OkV/cm (C). 60kV/cm. 
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Discussion 
Previous in vitro and in vivo studies suggest nsPEFs initiate apoptosis induction. 
The application of these ultrashort pulse durations has been illustrated to activate 
caspases, intracellular proteases essential in the apoptotic process, phosphatidylserine 
externalization, enhanced pro-apoptotic protein Bax activity and DNA fragmentation all 
associated with apoptosis (Beebe et al, 2003a; Vernier et al., 2003; Stacey et al., 2003; 
Vernier et al., 2004; Hall et al., 2007). Initial research in mouse B10-2 fibrosacoma 
tumors reported nsPEFs initiate caspase activation and DNA fragmentation by TUNEL 
ex vivo while tumor reduction was observed in vivo (Beebe et al, 2002). Recent studies 
in B16F10 mouse melanoma cells showed tumor regression though precise mechanism 
involved with tumor shrinkage was not well defined (Nuccitelli et al., 2006). The results 
paved the way to further investigate cell death mechanism in vitro associated with 
nsPEFs applications. 
Here the administration of 300ns pulses ranging from 12kV/cm-60kV/cm were 
applied to B16F10 mouse melanoma cells. As detected in earlier studies, the 
administration of nsPEF treatments induced caspase activity in B16F10 melanoma cells. 
The data reveal that the application of 300ns pulses ranging from 12kV/cm-60kV/cm 
enhances caspase activity in an electric field and pulse number dependent manner 
measured two hours post treatment. Neither one nor three pulses were sufficient to 
stimulate an electric field dependent increase in caspase activity nor to result in a 
decrease in cell number. However, ten pulses were sufficient to overcome threshold that 
recruits a greater population of cells for caspase activity in an electric field dependent 
manner. For the first time electric field and pulse number dependent increase in caspase 
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activation was correlated with cell survivability twenty four hours post pulse. Since 
caspases are known to be involved in the eventual death of the cell, data suggest that 
nsPEFs mediate a caspase-dependent apoptosis linked with cell death. In addition, results 
using Yo-Pro-1 as an apoptotic indicator displayed an electric field dependent increase 
correlated with caspase activity. The results further support a caspase-dependent 
apoptosis induced by nsPEFs. 
Another distinct feature of apoptosis is characterized by effects on the plasma 
membrane. Pores created in the plasma membrane can have a significant impact on cell 
viability. Convectional electroporation, which was generally designed to maximize cell 
survival, deliver long electrical pulses ranging in durations from milliseconds to 
microseconds that form large pores in the plasma membrane that significantly enhance 
the flow of ions and molecules across the plasma membrane (Weaver, 1995). This 
application has been shown to be advantageous in procedures such as DNA transfection 
or transformation (Nickoloff, 1995), cancer tumor electrochemotherapy (Dev and 
Hofmann, 1994), gene therapy (Tjelle et al., 2006) and trans-dermal drug delivery 
(Prausnitz et. al, 1993). On the other hand, formation of large pores allows non-specific 
molecules to move in and out of the cell that could lead to improper cell function and cell 
death (Weaver, 1995). Along these lines, specific damage to cells using irreversible 
electroporation is now in use as a means to eliminate cancer. 
In contrast, nanosecond pulses have much shorter pulse durations and display 
differential effects on the plasma membrane, which may not always be observable using 
propidium iodide uptake, and alterations in phosphatidylserine externalization (PS). 
Based on in silico studies by Gowrishankar et al. (2006) and Smith and Weaver (2008), 
nsPEFs result in supra-electroporation of the plasma membrane and organelle membranes 
with high densities of nanopores. These nanopores are on the order of 1 nm which is 
about the size of propidium iodide. The measurement of membrane permeability by 
propidium iodide uptake suggests nsPEFs induce a biological effect on the plasma 
membrane and not a direct effect on plasma membrane (Beebe et al., 2003; Chen et al., 
2004). Similar observations were revealed in the uptake of propidium iodide in B16F10 
melanoma cells. Initial results demonstrated no effect on the plasma membrane with one 
and three pulses whereas ten pulses illustrated an electric field and pulse number 
dependent increase for propidium iodide uptake. Furthermore, maximal plasma 
membrane permeability was observed by propidium iodide uptake within fifteen minutes 
of sixty minute time course post nsPEF application in the absence and presence of 
propidium iodide. Approximately thirty percent more cells pulsed in the presence of 
propidium iodide took up propidium iodide. It is likely that nsPEFs induce nanopore 
formation in B16F10 membranes that are too small to allow propidium iodide uptake. 
Thus, the observed PI uptake that is time dependent in a population of cells is likely due 
to the later stages of apoptosis where the plasma membrane begins to loose integrity. 
A different marker to evaluate changes at the plasma membrane uses Annexin V 
that measures externalization of phosphatidylserine phospholipids exposed during 
apoptosis. NsPEF initiate alterations in PS as shown in Jurkats (Beebe et al., 2003a; 
Vernier et al., 2004) that differs in B16F10 melanoma cells. Minimal PS externalization 
was observed regardless of the nsPEF condition in B16F10 melanoma cells. However, 
B16 cells can externalize PS evident by phloretin treated cells which suggest that 300ns 
PEFs condition does not externalize PS. Thus, the absence of PS externalization appears 
to be unique to nsPEF-induce caspase dependent apoptosis in comparison to phloretm-
induced apoptosis and caspase dependent apoptosis demonstrated in Jurkats and HCT 
116 cells (Beebe et al., 2003a; Hall et al., 2005). 
Further evaluation of morphological changes indicative of apoptosis that involve 
the plasma membrane additionally strengthen nsPEF involvement in this form of 
programmed cell death. The loss of the active cytoskeleton and the presence of 
membrane blebbing are two such changes that occur during apoptosis and are likely 
related. The activation of caspases may mediate membrane blebbing since actin is a 
target for caspase proteolysis (Coleman et al., 2001). Here membrane blebbing was 
visible by bulging out pockets of plasma membrane under 300ns 60kV/cm pulse 
conditions. 
The release of calcium intracellular signaling molecule from intracellular 
organelles plays a key role in many physiological and cellular functions such as apoptosis 
induction (Zhang et al., 2006). The mobilization of intracellular calcium has been linked 
to caspase activation and DNA fragmentation by Ca2+-dependent endonucleases 
(Mattson, 2003; Bortner et al., 1995). However, studies have demonstrated apoptosis 
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induction independent of Ca fluctuations (Grubb 2001). According to study conducted, 
no differences in the levels of intracellular calcium release were observed under nsPEF 
conditions ranging from 12-60kV/cm though calcium mobilization from intracellular 
induced by nanosecond pulse conditions has been reported (Vernier et al., 2003; White et 
al., 2004; Zhang et al., 2008). The data suggest an electric field dependent increase in 
caspase activation independent of intracellular calcium release. However, significant 
differences between BAPTA-AM +/- group at 60kV/cm indicate that at ten 300ns pulses 
at 60kV/cm calcium may potentially have an inhibitory role in caspase activation. 
Several characteristic morphological changes occur during apoptosis. The 
cytoskeleton structure is composed of three kinds of filaments, actin filaments 
(microfilaments), intermediate filaments, and microtubules that provide shape and 
structure to the cell. Caspases are known to be responsible for cellular breakdown and 
mediate actin disruption (Watanabe and Akaike, 1999; Slee et al., 2001). In vitro study 
in B16F10 melanoma cells illustrated actin cytoskeleton breakdown induced by nsPEFS 
similar to previous report in HCT 116 carcinoma cells (Hall et al., 2007). At nsPEF 
conditions of 300ns 60kV7cm and ten pulses, the majority of cells lost their F-actin 
cytoskeletal integrity within two hours of treatment. Different cytoskeletal effects were 
observed with phloretin treated cells which maintained their integrity within two hours of 
treatment. This indicates that nsPEF treated cells are in a later stage of apoptosis in 
comparison to phloretin treated cells. Also caspases may contribute to this breakdown as 
indicated in previous observations. 
Caspase activation occurs within the first hour after application of nsPEFs. 
Apoptosis takes place in three phases, initiation, a latent phase and an execution phase. 
For nsPEFs, it appears that the initiation phase and the latent phase are relatively short 
since caspase activation marks the execution phase within the first hour. This suggests 
that nsPEFs induce an insult that is rapidly perceived as a clear and present danger that 
cannot co-exist with survival and the apoptosis program is quickly initiated. 
Overall, data illustrates that nsPEFs induce apoptosis characterized by a rapid 
electric field dependent increase in calcium-independent caspase activation in the absence 
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of PI uptake or PS externalization, and a disruption of F-actin cytoskeletal structure with 
membrane blebbing. This paves the way in the next chapter to further examine specific 
apoptotic pathway(s) associated with apoptotic induction in B16F10 melanoma cells. 
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CHAPTER III 
NANOSECOND PULSED ELECTRIC FIELDS INDUCE APOPTOSIS 
INDEPENDENT OF MITOCHONDRIA IN B16F10 MELANOMA 
CELLS IN VITRO 
INTRODUCTION 
Apoptosis mechanisms are complex. The fate of the cells depends on a 
complex set of sensors and positive and negative regulators whose balance will determine 
whether apoptosis is initiated or not. Unfortunately, no linearly defined apoptosis death 
pathways exists, but for convenience they are frequently grouped into two main 
categories including an intrinsic mechanism, which is linked to the mitochondria, and an 
extrinsic mechanism, which is linked to death receptors in the plasma membrane. The 
intrinsic pathway is dependent upon the mitochondrial release of cytochrome c activation 
in response to intracellular stresses such as DNA damage, serum deprivation, and stress 
to endoplasmic reticulum (Adams, 2003; Aoki 1996). The Bcl-2 family of proteins 
consists of pro- and anti- apoptotic members associated with the mitochondria's role in 
apoptosis. The sensitivity of cells to apoptotic stimuli depend on the balance between 
pro- and anti- apoptotic proteins. The increase in pro-apoptotic protein levels such as 
Bax disrupts the normal function of the anti-apoptotic Bcl-2 proteins leading to pore 
formation in the mitochondria. The alteration in the mitochondrial membrane potential 
leads to release of mitochondrial protein cytochrome c, which binds to cytosolic proteins, 
APAF-1 and pro-caspase -9 to form the apoptosome, which proteolytically activates 
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caspases -9 leading to activation of executioner caspases -3, -6 and -7 and ultimately cell 
death (Albert, 2002). 
Additionally, the mitochondria release other mitochondrial proteins in similar 
manner to cytochrome c. The release of Smac/DIABLO interacts with the IAP family of 
apoptosis inhibitory proteins to neutralize their anti-apoptotic activity to induce cell death 
(Hengartner, 2000). Also mitochondrial release of apoptosis inducing factor (AIF) 
initiates DNA fragmentation and nuclear morphological changes such as chromatin 
condensation that is associated with apoptotic cell death (Jacobson and McCarthy, 2002). 
The extrinsic pathway consists of a mitochondrial-independent (type I) and 
mitochondrial-dependent (type II) apoptotic induction dependent on signaling through the 
plasma membrane. The extrinsic type I pathway is initiated by interaction between the 
death receptors (Fas, TNF, TRAIL) and death ligands. As a result of this interaction 
death adaptor proteins (FADD, TRADD) are recruited to the cytosolic domains of the 
receptors in the plasma membrane. The death inducing signaling complex (DISC) forms 
with the adaptor proteins and pro-caspase 8, which leads to activation of caspase -8 and 
then activation of caspase -3. The extrinsic mitochondria-dependent type II pathway, 
utilizes death receptors however, caspase -8 cleaves pro-apoptotic protein, Bid. The 
truncated Bid (t-Bid) acts on the mitochondria to cause cytochrome c release, thus 
activating caspase -9 in the apoptosome and then -3. Thus t-Bid connects the extrinsic 
pathway to the intrinsic pathway. 
As mentioned previously, reports have suggested that nsPEFs initiate caspase-
dependent apoptotic cell death measured by various apoptotic indicators. However the 
apoptotic mechanisms and pathway(s) require further definition. Thus far only one study 
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performed in Jurkats T lymphocytes has pointed toward the involvement of a 
mitochondria dependent apoptotic pathway observed by cytochrome c release from 
mitochondria and caspase activation (Beebe et al., 2003). Based on experimental data 
from Chapter 2 that nsPEFs induce apoptosis in B16F10 melanoma cells in vitro leads to 
further assessment of specific apoptotic pathway(s) through which these events take 
place. The examination of the intracellular release of mitochondrial proteins, cytochrome 
c, Smac/DIABLO and AIF and the identification of specific initiator caspases -8 and-9 
and executioner caspases -3, -6, and -7 would clarify whether an intrinsic or extrinsic 
type II mitochondrial dependent or extrinsic type I mitochondrial independent apoptotic 
pathway is involved in this cell death process. 
The results showed no mitochondrial involvement in the induction of apoptosis 
induce by nsPEFs as revealed by the absence of release of mitochondrial proteins 
cytochrome c, Smac/DIABLO and AIF. Though initiator caspase -8 and executioner 
caspases -3, -6 and -7 were detected, interestingly caspase -9 activation was also 
apparent. The known mechanism for caspase -9 activation requires apoptosome 
formation through mitochondria release of cytochrome c and APAF-1 was not identified 
in experiment. Data suggest that nsPEFs initiate a mitochondrial independent apoptosis 
that may induce cell death signaling that involves the plasma membrane. Although no 
mitochondrial activity was observed, nsPEFs trigger caspase -9 activation via direct 




Mouse melanoma cells (B16F10) used in study was obtained from ATCC 
(Manassas, VA). B16 cells grown in Dulbecco's Modified Eagle's Medium with L-
glutamine (ATCC; VA) supplemented with 10% fetal bovine serum (Atlanta Biologicals; 
Nocross, GA), 1% L-glutamine and 1% penicillin streptomycin (Mediatech Cellgro; VA) 
and placed in incubator at 37°C with 5% CO2. 
Cell Preparation 
B16F10 cells for treatment were detached from cultured flask when cells are 
about 80-90% confluent. This involves removal of media from flask, a rinse with Hank's 
Balanced Salt Solution IX (Mediatech Cellgro;VA), trypsin EDTA IX 
0.25%trypsin/2.21mM EDTA in HBSS addition (Mediatech Cellgro;VA) and DMEM 
culture medium addition. B16F10 cell preparation prior to pulse involves centrifugation 
at lOOOrpm and addition of Dulbecco's Phosphate Buffered Saline (DPBS) solution 
which contains 0.5mM CaCl2.2H20, 4.2mM KC1, KH2P04, 0.5mM MgCl2.6H20, 
153mM NaCl, 9.5mM Na2HP04.7H20 and 2.5mM glucose, pH 7.4. Cell count was 
performed using a hemacytometer, centrifugation at 1000 rpm and DPBS solution 
addition based on 7.7x106cells/mL. 
Administration of nsPEF 
Trypsinized B16 cells 7.7xl06cells/mL are exposed to nsPEF conditions at a 
concentration of lxl06cells/130uL placed in 0.1cm gene pulser cuvettes (Bio-Rad 
Laboratories; Hercules, CA). Rectangular high voltage pulses of 300 ns duration and 
amplitudes of 1.2-6.0 kV are applied by transmission line type pulse generator to the 
plane parallel electrodes in the cuvette. Representative pulse shapes are shown in Figure 
1. The 10-Ohm impedance of the pulse generator is matched to the resistance of the 
exposed sample. With increasing voltage, the rise time of the pulses increases slightly 
from 15.3 to 19.1 ns. The applied voltages correspond to homogeneous electric fields of 
12-60 kV/cm in the cuvette. 
Measurement of Cytochrome C, Smac/DIABLO and AIF Release From the 
Mitochondria 
B16F10 melanoma cells were prepared and exposed to nsPEFs as previously 
mentioned, incubated with monoclonal antibodies for cytochrome c (BD Pharmingen; 
San Jose, CA), SMAC/DIABLO (Calbiochem; Gibbstown, NJ) and AIF (Santa Cruz 
Biotechnology; Santa Cruz, CA) for one hour. Cells were washed in lmL of modified 
phosphate buffer followed by one hour incubation with Alexa Fluor 488 goat anti-mouse 
antibody (Invitrogen; Oregon) and washed in IX PBS. Fifteen thousand cells were 
acquired and analyzed by a Becton-Dickinson FACSCalibur flow cytometer. Data 
analysis was carried out by Cell Quest Pro software for fluorescence intensity 
measurement. 
Evaluation of Active Caspases -8, -9, -6, -3 & -7 by Flow Cytometry 
Cells were prepared and exposed to nsPEF conditions as previously mentioned. 
Live cells were according to manufacturer's instructions from Carboxyfluorescien 
FLICA Kit (Immunochemistry Technology LLC; Minnesota) specific for caspases -8, -9 
and -6 and Sulforhodamine FLICA Kit (Immunochemistry Technology LLC; Minnesota) 
specific for caspases -3 and -7. Ten thousand cells were acquired using BD FACS Aria 
and analyzed by BD FACSDiva software. 
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Evaluation of Active Caspases -8, -9, -6, -3 & -7 by Fluorescence Microscopy 
Cells were prepared and exposed to nsPEF conditions as previously mentioned. 
Cells were fixed according to manufacturer's instructions from Carboxyfluorescien 
FLICA Kits (Immunochemistry Technology LLC; Minnesota) specific for caspases -8, -9 
and -6 and Sulforhodamine FLICA Kit specific for caspase -3 and -7 (Immunochemistry 
Technology LLC; Minnesota). Cells were dried on slides overnight in the incubator at 
37°C with 5% CC*2, cover slipped and mounted with 4 ,6-diamidino-2-phenylindole, 
dihydrochloride (DAPI) for nuclei staining. Cells were viewed by an Olympus BX51 
microscope and images captured by DP70 camera. 
RESULTS 
Cytochrome C release is undetectable in B16F10 melanoma cells post pulse. 
In order to determine whether nsPEFs induce apoptosis through an intrinsic or 
extrinsic pathway that involves the mitochondria, cytochrome c release was examined. 
Figure 11 shows that cytochrome c remains undetected for 5 hours post pulse. A 2-fold 
increase in about 50% of the cells was observed at 7 hours in comparison to earlier time 
point. In contrast, phloretin induced a time dependent increase in cytochrome c release 
indicating that B16F10 cells can function through a mitochondria dependent mechanism, 
but not in response to nsPEFs. 
Mitochondrial proteins, Smac/DIABLO and AIF release undetectable in B16F10 
melanoma cells upto to 3hrs post pulse. 
In addition to investigating the mitochondria via cytochrome c release, other 
mitochondrial proteins, Smac/DIABLO and AIF that are released during apoptotic 
induction were assessed. Figure 12 illustrates no release of mitochondrial proteins 
56 
Smac/DIABLO or AIF. In contrast, phloretin treated cells exhibited an approximate 4 to 
5 and 2.5 to 4 fold increase in fluorescence intensity for Smac/DIABLO and AIF 
respectively within 3 hours post pulse. Thus, release of these pro-apoptotic proteins can 
function in B16F10 cells, but not in response to nsPEFs. 
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FIGURE 11 No detection of cytochrome c release in B16F10 melanoma cells 
exposed to nsPEFs 5hrs post pulse. B16F10 melanoma cells were exposed to 
ten 300ns pulses at 12, 26, and 60kV/cm or 200uM phloretin for one hour, 
incubated with monoclonal anti-cytochrome c antibody, followed by 
incubation with Alexa Fuor 488 goat anti-mouse antibody. Cytochrome c 
fluorescence intensity is indicated as the geometric mean lhr (n=3), 3hrs 















FIGURE 12 NsPEFs have minimal effects on the release of mitochondrial proteins 
SMAC/DIABLO and AIF. B16F10 melanoma cells were exposed to ten 300ns pulses ranging 
from 12 -60kV/cm or 200 | JM phloretin for one hour, incubated with monoclonal 
SMAC/DIABLO and AIF antibodies, followed by incubation with Alexa Fluor 488 goat anti-
mouse antibody. SMAC/DIABLO and AIF fluorescence intensity is indicated as the geometric 
mean at 3hrs (n=4 & 5 respectively). 
NsPEFs induce activation of initiator caspases -8 and -9. 
The flow cytometry data represented in Figure 13 demonstrates an electric 
dependent increase in both the activation of initiator caspases -8 and -9 with 
approximately 60% of cell population demonstrating activity at 60kV/cm. Similar 
observations were viewed in fluorescent microscopy images where over 60% cell 
population demonstrated both active caspase -8 and -9 indicated by intracellular green 
fluorescence in Figure 14 and 15 respectively in response to at electric field condition 
60kV/cm. Activation of initiator caspases -8 and -9 were observed in phloretin-treated 
cells. 
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FIGURE 13 NsPEF induce activation of initiator caspases -8 and -9 
in an electric-field dependent manner. Cells were exposed to ten 
pulses ranging from 12-60kV/cm or 200uM phloretin for one hour 
and percentage of cells active for caspases -8 and -9 measured using a 
FAM-LETD-FMK and FAM-LEHD-FMK In Situ marker, 
representatively. Cells analyzed by flow cytometry 2 hours post pulse 
(n=5 except OkV/cm). 
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FIGURE 14 NsPEFs induce activation of initiator caspase -8. B16F10 melanoma cell were treated 
with ten 300ns pulses at 60kV/cm or 200 uM phloretin for two hours, incubated with FAM-LETD -
FMK indicator, fixed two hours post pulse, dried in an incubator at 37°C overnight, mounted with 
DAPI (stains nucleus), cover slipped and viewed by an Olympus BX 51 microscope and cells were 
captured with DP70 camera. 
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FIGURE 15 NsPEFs induce activation of initiator caspase -9. B16F10 melanoma cell were treated 
with ten 300ns pulses at 60kV/cm or 200uM phloretin for two hours, incubated with FAM-LEHD -
FMK indicator, fixed two hours post pulse, dried in an incubator at 37°C overnight, mounted with 
DAPI (stains nucleus), cover slipped and viewed by an Olympus BX 51 microscope and cells were 
captured with DP70 camera. 
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NsPEFs induce activation of executioner caspases -3, -6 and -7 
The data represented in Figure 16 demonstrates an electric-field dependent 
increase in the activation of executioner caspases, -3, -6 and -7 with approximately 60% 
of cell population expressing activity at 60kV/cm. Similar results were displayed four 
hours post pulse (data not shown). Comparable observations were viewed in fluorescent 
microscopy images where about 80% and 70% of cell population demonstrated both 
active caspase -6 and -3/-7 indicated by intracellular green and red fluorescence in Figure 
16 and 17 respectively at electric field condition 60kV/cm. Active executioner caspases -
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FIGURE 16 NsPEF induce activation of executioner caspases -3, -6 
& -7 in an electric-field dependent manner. Cells were exposed to ten 
pulses ranging from 12-60kV/cm or 200uM phloretin for one hour 
and percentage of cells active for caspases -6 and -3 & -7 measured 
using a FAM-VEID-FMK and SR-DEVD-FMK In Situ marker, 
representatively. Cells analyzed by flow cytometry 2 hours post pulse 
(n=4). 
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FIGURE 17 NsPEFs induce activation of executioner caspases -6. B16F10 melanoma cell were 
treated with ten 300ns pulses at 60kV/cm or 200uM phloretin for one hour, incubated with FAM-
VEID-FMK indicator, fixed two hours post pulse, dried in an incubator at 37°C overnight, mounted 
with DAPI (stains nucleus), cover slipped and viewed by an Olympus BX 51 microscope and cells 
were captured with DP70 camera. 
FIGURE 18 NsPEFs induce activation of executioner caspases -3 & -7. B16F10 melanoma cell were 
treated with ten 300ns pulses at 60kV/cm or 200uM phloretin for two hours, incubated with SR-
DEVD -FMK indicator, fixed two hours post pulse, dried in an incubator at 37°C overnight, mounted 
with DAPI (stains nucleus), cover slipped and viewed by an Olympus BX 51 microscope and cells 
were captured with DP70 camera. 
DISCUSSION 
Numerous studies have recognized nsPEF-induced apoptotic cell death 
distinguished by caspase activation, PS externalization, propidium iodide uptake, DNA 
fragmentation, cytochrome c release and pro-apoptotic protein, BAX (Beebe et al, 2003a; 
Stacey et al., 2003; Vernier et al., 2004; Hall et al , 2007). The experimental data in 
Chapter 2 demonstrated similarities in apoptotic induction by nsPEFs in B16F10 
melanoma cells by caspase activation although no PS externalization was identified. To 
further strengthen apoptosis induction I illustrated morphological changes of plasma 
membrane blebbing and cytoskeleton disruption, which were not shown previously in 
response to nsPEFs. Only one study suggested that nsPEFs may potentially induce cell 
death through a mitochondrial dependent apoptosis mechanism identified by 
mitochondria release of cytochrome c in Jurkat cells (Beebe et al, 2003). However, this 
study does not specify whether apoptotic induction by nsPEFs occurred through a 
mitochondrial dependent intrinsic pathway or a type II extrinsic apoptotic pathway 
(Beebe et al., 2003a). 
Intracellular proteins are associated with the classification of specific apoptotic 
pathways. The mitochondria function plays an essential part in defining the intrinsic or 
extrinsic type II apoptotic pathway through release of mitochondrial proteins necessary to 
complete execution of cell death. The mitochondria release of cytochrome c, more 
importantly is an essential protein required for the activation of initiator and executioner 
caspases through the mitochondria-dependent pathways. In vitro evaluation in B16F10 
melanoma cells displayed no detection of cytochrome c release from the mitochondria up 
to seven hours post nsPEF application. However, at seven hours an approximate 2.5 fold 
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increase in comparison to five hours was observed. The event is far too late for the 
involvement in caspase activation observed in less than one hour post pulse. In addition 
to the absence of mitochondria cytochrome c release, similar results were revealed with 
other mitochondrial proteins, Smac/DIABLO and AIF, indicating that nsPEFs initiate a 
mitochondria independent apoptosis. In contrast B16F10 melanoma cells treated with 
anticancer agent phloretin demonstrated release of mitochondrial protein cytochrome c 
indicating that a mitochondrial dependent apoptotic pathway can be activated in B16F10 
cells, but not by nsPEFs. Also the observed release of additional mitochondrial proteins 
Smac/DIABLO and AIF supports the mitochondria involvement in apoptotic cell death 
mechanism in response to phloretin, but not by nsPEFs. This eliminates the possibility 
that B16F10 melanoma cells are incapable of releasing mitochondrial proteins and 
suggest differential effects in apoptotic induction between phloretin and nsPEFs. 
Earlier reports have showed that pulse electric fields stimulate a caspase-
dependent apoptosis. However specific caspase(s) involvement in the process was not 
investigated (Beebe et al., 2003a). In this study initiator caspases -8 and -9 were 
investigated to further determine a mitochondria dependent or independent apoptotic 
pathway. The data represented demonstrates an electric field dependent increase in both 
initiator caspases -8 and -9 despite the absence of cytochrome c release from the 
mitochondria, which is the only known mechanism for caspase -9 activation. In addition, 
data was further supported by the expression of active caspase -8 and -9 in fluorescent 
microscopy images. The activation of caspase -9 along with the absence of mitochondria 
release of cytochrome c implies the possibility that there maybe some other mechanism 
besides apoptosome formation with cytochrome c and APAF-1 for activation of caspase -
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9 by nsPEFs. Data illustrated that nsPEFs activates caspase -8 which would suggest 
apoptotic induction through effects on the plasma membrane that would mimic a 
mitochondrial independent type I apoptotic pathway. Additional studies are required to 
examine factors associated with plasma membrane that activates caspase -8 to support 
this hypothesis. 
The initiator caspases are responsible for activating executioner caspases that 
results in cellular destruction defining the characteristic features of apoptosis. NsPEFs 
were shown to initiate the activation of executioner caspases -3, -6 and -7 in an electric 
field dependent manner corresponding with fluorescent microscopy images strengthening 
executioner caspases association in apoptotic induction. Data suggest that nsPEFs initiate 
activation of executioner caspases either through direct cleavage of executioner caspases, 
direct cleavage of initiator caspases leading to executioner caspase activation or through 
an extrinsic type I apoptotic pathway that elicit effects through the plasma membrane. As 
demonstrated in Chapter II, the plasma membrane markers that were used here including 
propidium iodide and Annexin-V did not indicate any direct effects on the plasma 
membrane. However, Yo-Pro-1, which is similar in size to propidium iodide and has 
been reported to be specific for apoptotic cells, did cross the plasma membrane indicating 
selective uptake of Yo-Pro-1 but propidium iodide uptake. 
The evasion of cell death via mutations in apoptosis mechanisms is a major step 
toward malignant transformation and therapeutic resistances. Furthermore, inactivation 
of apoptosis mechanisms is a hallmark of cancer and an obligate aspect for the malignant 
transformation of normal cells. Apoptosis pathways mediated by mitochondria exhibit 
many of the mutations that occur in melanoma. These mitochondria mediated pathways 
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are commonly activated by chemotherapeutic agents, which often develop resistances. 
The application of short treatment time for nsPEFs (3 milliseconds) and the rapid 
activation of caspases (tens of minutes) prove advantageous in apoptosis induction 
without utilizing mitochondria dependent apoptotic pathway that many 
chemotherapeutics uses in the initiation of cell death. 
In summary, the data revealed that nsPEFs induce a mitochondrial independent 
apoptosis that involves activation of initiator caspases -8 and unexpectedly caspase -9. 
This is likely through direct cleavage or an unknown mechanism that is independent of 
apoptosome formation. In addition the activation of executioner caspases -3, -6 and -7 
maybe responsible for mediating morphological changes indicative of apoptosis such as 
plasma membrane blebbing and F-actin cytoskeleton disruption. Overall, nsPEFs initiate 





The mechanism of apoptosis induction in B16F10 melanoma cells differs between 
treatment with the anticancer drug, phloretin and nsPEFs. Phloretin mediates both a 
mitochondrial dependent intrinsic and type II apoptotic pathway. However, nsPEF-
induced melanoma cell death is mediated by a caspase-dependent, calcium and 
mitochondrial-independent apoptotic induction. NsPEF-induced apoptosis did not reveal 
effects through the plasma membrane such as phosphatidylserine externalization. The 
most intense nsPEF conditions tested (ten 300ns pulses at 60kV/cm) did not induce a 
direct electric field effect on membrane permeability measured by propidium iodide 
uptake. Changes in membrane permeability were time-dependent biological response to 
nsPEFs. NsPEFs induce cell death in B16F10 melanoma cells in vitro that differs from 
the conventional intrinsic and extrinsic apoptotic pathway. However nsPEFs induce 
caspase-dependent apoptosis through pathways that are generally not used by 
chemotherapeutic agents and ionizing radiation, which often require mitochondria-
mediated mechanisms. Many cancer causing mutations in melanoma occur in the 
mitochondria pathways but can occur in plasma-mediated apoptosis mechanisms. 
Regardless of any mutations that may occur in B16F10 melanoma cells, nsPEFs can 
rapidly bypass mitochondria-dependent apoptosis and cause caspase-dependent cell 
death. This rapid induction of apoptosis and the short treatment time (milliseconds to 
seconds) for nsPEFs are less likely to induce resistant cancers. Unlike chemotherapy 
nsPEFs do not have systemic side effects and unlike surgery it is minimally invasive and 
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leaves no scars. Therefore, the therapeutic application of nsPEFs can provide an 




The experimental data proves that nsPEFs induce cell death via a mitochondrial 
independent apoptotic pathway suggesting an extrinsic type I pathway that involves the 
plasma membrane. In general, the extrinsic type I pathway becomes activated through 
activation of death receptors and death ligands. Death domain receptors recruit death 
adaptor proteins (FADD, TRADD), pro-caspase-8 and forms DISC that leads to caspase -
8 activation followed by caspase -3. This pathway can be inhibited by c-FLIP which 
blocks caspase -8 thus preventing caspase -8 recruitment to DISC, resulting in inhibition 
ofapoptosis. 
In order to conclusively identify this pathway would require further investigation 
of proteins associated with the plasma membrane. One approach would be to transform a 
c-FLIP plasmid into bacteria and then transfect it into B16F10 melanoma cells. This 
would be followed by examination of caspase -8 activity when nsPEFs are administered 
to indicate the involvement of the extrinsic type I pathway. The anticipated results 
should demonstrate a significant reduction in the percentage of cells that express caspase 
-8 in comparison to cell without c-FLIP plasmid. 
Another approach would be to inhibit caspase -8 and examine the percentage of 
cells that express executioner caspases -3, -6 and -7 in comparison to cells without 
caspase -8 inhibitor. The rapid activation of nsPEF-induced caspase activity suggests 
that transcription dependent events are unlikely involved caspase activation. Information 
could be gained by to investigating changes in the levels of proteins that might be 
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transcription dependent, such as Bcl-2 family members and survival proteins. While 
these events may occur in steps post-caspase activation, that nsPEFs induce processes 
causing caspase activation remains to be identified. 
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